|
|||||
|
|
| 早产儿异基因细胞移植免疫耐受的研究进展 | |
| 引用本文： | 吕灿,屈艺,母得志. 早产儿异基因细胞移植免疫耐受的研究进展[J]. 中国当代儿科杂志, 2018, 20(4): 338-340. DOI: 10.7499/j.issn.1008-8830.2018.04.016 |
| 作者姓名： | 吕灿 屈艺 母得志 |
| 作者单位： | 吕灿, 屈艺, 母得志 |
| 基金项目： | 国家重点研发计划项目（2017YFA0104204）。 |
| 摘 要： | 早产儿是一类特殊的群体，与早产相关的严重神经、呼吸、消化系统疾病的致残/致死率居高不下。异基因细胞移植可能是上述疾病治疗和预防的有效手段。目前，异基因细胞移植治疗缺氧缺血性脑病、支气管肺发育不良以及坏死性小肠结肠炎的动物实验已成功开展。而异基因细胞移植治疗早产儿疾病所面临的困难主要是移植物抗宿主反应，而要解决这一问题，需要实现免疫耐受的成功诱导。本文就近年来早产儿异基因细胞移植免疫耐受的研究进展进行综述。 |
| 关 键 词： | 异基因细胞移植 移植物抗宿主反应 免疫耐受 早产儿 |
| 收稿时间： | 2017-12-08 |
| 修稿时间： | 2018-02-10 |
Research advances in immune tolerance of allogeneic cell transplantation in preterm infants |
|
| LYU Can,QU Yi,MU De-Zhi. Research advances in immune tolerance of allogeneic cell transplantation in preterm infants[J]. Chinese journal of contemporary pediatrics, 2018, 20(4): 338-340. DOI: 10.7499/j.issn.1008-8830.2018.04.016 | |
| Authors: | LYU Can QU Yi MU De-Zhi |
| Affiliation: | LYU Can, QU Yi, MU De-Zhi |
| Abstract: | Preterm infants are a special group, and related severe neurological, respiratory, and digestive disorders have high disability/fatality rates. Allogeneic cell transplantation may be an effective method for the prevention and treatment of these diseases. At present, animal studies have been conducted for allogeneic cell transplantation in the treatment of hypoxic-ischemic encephalopathy, bronchopulmonary dysplasia, and necrotizing enterocolitis. The main difficulty of this technique is graft-versus-host reaction (GVHR), and successful induction of immune tolerance needs to be achieved in order to solve this problem. This article reviews the research advances in immune tolerance of allogeneic cell transplantation in preterm infants. |
| Keywords: | Allogeneic cell transplantation|Graft-versus-host reaction|Immune tolerance|Preterm infant |
| 本文献已被 CNKI 等数据库收录！ | |
| 点击此处可从《中国当代儿科杂志》浏览原始摘要信息 | |
| 点击此处可从《中国当代儿科杂志》下载全文 | |